Zacks Industry Outlook Highlights Chemed, Addus HomeCare, RadNet and The Pennant Group

For Immediate Release

Chicago, IL March 24, 2023 Today, Zacks Equity Research discusses for Chemed Corp. CHE, Addus HomeCare Corp. ADUS, RadNet, Inc. RDNT and The Pennant Group, Inc. PNTG.

Industry: Healthcare - Outpatient & Home

Link: https://www.zacks.com/commentary/2069569/4-promising-stocks-from-a-challenging-outpatient-home-health-industry

The pandemic altered the nature and dynamics of the healthcare industry. The Zacks Medical - Outpatient and Home Healthcare industry bore the brunt of lower outpatient clinic visits and struggled to provide quality care with respect to home healthcare due to the risk of exposure to the virus as well as the record level of staffing shortages. In recent times, although the severity of the infection has declined, there has been a circulation of a mixture of respiratory viruses per a recently-published data published by the Centers for Disease Control and Prevention.

Apart from the respiratory ailments, the U.S. healthcare system is also currently being bothered by the recent increasing threat of spread of the antimicrobial resistant fungus Candida auris (C. auris) in healthcare facilities. Another concern plaguing the U.S. healthcare system is the persistent cost inflation and supply-chain constraints. These are consistently pushing up the operating costs of the healthcare industry, thereby lowering the margins of industry players.